



About NouBio Inc
NouBio Inc is a cell-based human longevity company with access to next generation deep technologies to transform the $7 trillion longevity industry.
​
The founding team is focused on the bio-intelligent manufacturing of animal serum replacements & artificial intelligence driven biocomputer deep technologies to reduce the costs of cell-based biomanufacturing by 95% & scale the production of novel cell-based human longevity applications.
​
​​
NouBio's deep technologies scale production in multiple industries that impact the progression of cell-based human longevity including cell-therapies, cell-vaccines, human tissue creation, cell-based blood, drug discovery, regenerative medicine, cell-based foods/materials, defense, & synthetic biology.
​​
​
First beta product:
​
NouSerum: A full Fetal Bovine Serum (FBS) replacement that reduces production costs by 95% with similar performance to FBS.
​
NouSerum:
​
-300 serum proteins found in FBS
-Is in the GRAS category of FDA
-Free from GMOs
-Powder for scalability
-Antimicrobial to reduce contamination
-Can be stored at room temperature
-GMP compliant
​
Future products:
​
-Cost-effective, bio-degradable microcarriers with no need to remove cells in bioreactors
​
-An artificial intelligence driven robotic cellular biocomputer to replace the need for bioreactors and scale cell-based applications in the longevity industry
Email info@noubio.co


Why is it still a myth?
The use of animal serum is preventing cultivated meat and cell-based biomanufacturing from becoming a reality. Serum that is sourced from harming animals keeps the costs high, and has many regulatory hurdles. The use of animal serum is keeping the price point of cultivated meat products high and preventing the scalability of the industry. Non-edible microcarriers create secondary problems in bioreactors where cells have to be removed prior to the final cultivated meat creation.
​
NouBio has the solution with our market ready products!

Regulations

High cost

Not scalable
